Boston Medical Sciences
Tokyo · Founded 2023
About Boston Medical Sciences
Boston Medical Sciences is the developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making. The company's platform utilizes artificial intelligence to perform virtual bowel cleansing, which helps prepare the colon for examination without the traditional discomfort associated with laxatives, enabling healthcare providers with enhanced detection and treatment through technology.
Company Facts
- Founded: 2023
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2025)
- Website: https://b-ms.tech/
Industries & Categories
Artificial Intelligence (AI), Big Data, Health Care, Medical
Canonical: https://fsome.com/organization/boston-medical-sciences-84113 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.